Topic: Transcatheter Mitral Valve Replacement System
LivaNova plans to restructure its heart valve operations, and will drop its investigational Caisson transcatheter mitral valve replacement altogether.
Polares Medical raised $25 million to begin clinical testing of its transcatheter mitral valve repair/replacement system.
Medtronic has posted a look at data on the first 50 patients treated with its transcatheter mitral valve replacement (TMVR) system.
Sofinnova Partners' investment in HighLife reunites it with Georg Börtlein, who helped drive CoreValve to a $700 million buyout from Medtronic.
LivaNova will acquire Caisson Interventional, a Minnesota-based heart valve maker, for $72 million.
Edwards Lifesciences has penned a deal to buy Valtech Cardio for up to $690 million, less than the heart valve company looked set to be acquired for last year.
